在重度抑郁症中接受胺治疗后,功能网络协同激活模式动态的调节
Brandon Taraku1, Jason S Nomi2, Artemis Zavaliangos-Petropulu1
1Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.
Imaging neuroscience (Cambridge, Mass.)
|October 20, 2025
概括
胺治疗改变了治疗耐药性抑郁症 (TRD) 患者的大脑网络动态,将活动模式转向健康对照者. 这些变化与反的减少相关,这表明胺的神经生物学基础.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 脑部成像 脑部成像
背景情况:
- 重度抑郁症与功能性大脑网络动态的改变有关.
- 氨酸在治疗耐药性抑郁症 (TRD) 中表现出快速的抗抑郁作用.
- 了解胺对大脑网络动态的影响对于TRD治疗至关重要.
研究的目的:
- 为了研究胺治疗是否调节TRD患者的功能性大脑网络动态.
- 为了确定与TRD临床改善相关的特定大脑网络变化.
主要方法:
- 休息状态功能磁共振成像 (fMRI) 用于58名TRD患者和56名健康对照 (HC).
- 同激活模式 (CAP) 分析确定了重复的脑活动模式及其时间动态 (时间分数 - FT,过渡概率 - TP).
- TRD患者在2周内接受了4次胺注射;评估是在基线和治疗后24小时进行的. 在两周的时间里,HC接受了类似的评估.
主要成果:
- 在TRD患者中,胺治疗减少了视觉网络 (VN) 的FT,并在中央执行网络 (CEN) 中增加了FT.
- 胺增加了从突出网络 (SN) 到CEN的过渡概率 (TP),并减少了从SN到VN的TP.
- 在SN中减少FT与改进的反得分相关;CEN和SN-CEN/SN-VN动态的基线差异区分了TRD和HC.
结论:
- 在TRD患者中,胺调节大脑网络动态,特别是涉及SN,CEN和VN.
- 这些动态变化可能会将TRD中观察到的异常网络模式正常化为健康个体的网络模式.
- 在胺治疗后,SN动态的改变与反症状的改善有关.
相关概念视频
Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Modeling in Therapy
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...


